The PBC Journey: Living
Find out what’s new and what’s next in treatment options for PBC.
-
-
CymaBay’s PBC therapy shows promising results in phase 3
-
Study: Off-label treatment shows promise in PBC
-
Ipsen-Genfit’s elafibranor shows promise in phase 3 PBC trial
-
Study: Deep learning could aid treatment of elderly adults with PBC
-
Obeticholic acid may reduce the risk of negative outcomes in PBC
-
Several potential treatments for PBC in focus at international liver conference
